{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:28:41Z","timestamp":1783646921523,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z191100006619111"],"award-info":[{"award-number":["Z191100006619111"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>IgG4-related ophthalmic disease (IgG4-ROD) is one of the phenotypes of IgG4-related disease (IgG4-RD), and its lesions are mainly located in the ocular. Currently, there are few studies on IgG4-ROD and no study has compared the phenotypic differences between IgG4-ROD and non IgG4-ROD (nIgG4-ROD). Thus, it is difficult to establish the optimal treatment strategy for IgG4-ROD. The aim of this study was to identify the disparities between the two groups and to clarify the risk factors for IgG4-ROD relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>434 IgG4-RD patients met comprehensive diagnostic criteria and\u00a0diagnosed at Peking University People\u2019s Hospital between January 2009 and January 2020 were recruited in this study. Patients were divided into IgG4-ROD and nIgG4-ROD group according to the ophthalmic involvement. Demographic, clinical, and laboratory data of two groups were collected and compared. Cox regression analysis was used to identify the independent risk factors for IgG4-ROD relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>255 IgG4-ROD patients were identified in this study. IgG4-ROD group had almost equal sex ratio, younger age of disease onset and diagnosis comparing with nIgG4-ROD patients. As compared to nIgG4-ROD group, higher percentage of IgG4-ROD patients met the 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria (AECC) for IgG4-RD; moreover, IgG4-ROD patients had higher AECC scores and IgG4-RD responder index (RI). Allergic diseases and multiorgan involvement were more common in IgG4-ROD group. IgG4-ROD was frequently associated with salivary gland, paranasal sinus, lung, and lymph node involvement, while retroperitoneal fibrosis and biliary system lesions were more common in nIgG4-ROD. IgG4-ROD patients had higher serum IgG4 levels, IgG4\/IgG ratio, IgE levels, and lower CRP levels. The initial glucocorticoid plus immunosuppressant was a protective factor for IgG4-ROD relapse. IgG4-ROD patients treated with initial glucocorticoid plus immunosuppressant had longer relapse-free survival time than patients treated with initial glucocorticoid monotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IgG4-ROD patients had distinctive clinical features compared with nIgG4-ROD patients. The initial glucocorticoid plus immunosuppressant was a protective factor for IgG4-ROD relapse, which could prolong the relapse-free survival time of IgG4-ROD patients. These findings may have important implications for understanding and management of IgG4-ROD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-021-02489-9","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T04:05:22Z","timestamp":1617163522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"issue":"10","key":"2489_CR1","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982\u20134. https:\/\/doi.org\/10.1007\/s00535-003-1175-y.","journal-title":"J Gastroenterol"},{"issue":"9976","key":"2489_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0.","journal-title":"Lancet"},{"issue":"1","key":"2489_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204907.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2489_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539\u201351. https:\/\/doi.org\/10.1056\/NEJMra1104650.","journal-title":"N Engl J Med"},{"issue":"3","key":"2489_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/rheumatology\/kez280","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xue M, Wang Z, Zeng Q, Ren L, Zhang Y, Zhang S, Wang Y, Shen D, Xia C, Yu G, Li ZG. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology. 2020;59(3):634\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kez280.","journal-title":"Rheumatology"},{"issue":"1","key":"2489_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","volume":"91","author":"M Ebbo","year":"2012","unstructured":"Ebbo M, Daniel L, Pavic M, S\u00e8ve P, Hamidou M, Andres E, Burtey S, Chiche L, Serratrice J, Longy-Boursier M, Ruivard M, Haroche J, Godeau B, Beucher AB, Berthelot JM, Papo T, Pennaforte JL, Benyamine A, Jourde N, Landron C, Roblot P, Moranne O, Silvain C, Granel B, Bernard F, Veit V, Mazodier K, Bernit E, Rousset H, Boucraut J, Boffa JJ, Weiller PJ, Kaplanski G, Aucouturier P, Harl\u00e9 JR, Schleinitz N. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine. 2012;91(1):49\u201356. https:\/\/doi.org\/10.1097\/MD.0b013e3182433d77.","journal-title":"Medicine"},{"issue":"1","key":"2489_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2214\/AJR.12.9995","volume":"201","author":"SS Hedgire","year":"2013","unstructured":"Hedgire SS, McDermott S, Borczuk D, Elmi A, Saini S, Harisinghani MG. The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol. 2013;201(1):14\u201322. https:\/\/doi.org\/10.2214\/AJR.12.9995.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2489_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","volume":"19","author":"M Ozawa","year":"2017","unstructured":"Ozawa M, Fujinaga Y, Asano J, Nakamura A, Watanabe T, Ito T, Muraki T, Hamano H, Kawa S. Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther. 2017;19(1):223. https:\/\/doi.org\/10.1186\/s13075-017-1432-8.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2489_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","volume":"19","author":"K Yamada","year":"2017","unstructured":"Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S, Kawano M. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262. https:\/\/doi.org\/10.1186\/s13075-017-1467-x.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"2489_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, Lo YF, Chan WK, Chan JK. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(8):1159\u201367. https:\/\/doi.org\/10.1097\/PAS.0b013e31816148ad.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2489_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","volume":"58","author":"Y Sato","year":"2008","unstructured":"Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, Takata K, Morito T, Kondo E, Yoshino T. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58(8):465\u201370. https:\/\/doi.org\/10.1111\/j.1440-1827.2008.02257.x.","journal-title":"Pathol Int"},{"key":"2489_CR12","doi-asserted-by":"publisher","first-page":"635473","DOI":"10.1155\/2012\/635473","volume":"2012","author":"M Takahira","year":"2012","unstructured":"Takahira M, Ozawa Y, Kawano M, Zen Y, Hamaoka S, Yamada K, Sugiyama K. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol. 2012;2012:635473.","journal-title":"Int J Rheumatol"},{"issue":"12","key":"2489_CR13","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/annrheumdis-2012-201477","volume":"71","author":"T Maehara","year":"2012","unstructured":"Maehara T, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Tanaka A, Shinozaki S, Kubo Y, Nakamura S. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease. Ann Rheum Dis. 2012;71(12):2011\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201477.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2489_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/s10165-011-0504-x","volume":"22","author":"S Matsui","year":"2012","unstructured":"Matsui S, Taki H, Shinoda K, Suzuki K, Hayashi R, Tobe K, Tokimitsu Y, Ishida M, Fushiki H, Seto H, Fukuoka J, Ishizawa S. Respiratory involvement in IgG4-related Mikulicz\u2019s disease. Mod Rheumatol. 2012;22(1):31\u20139. https:\/\/doi.org\/10.3109\/s10165-011-0504-x.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2489_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21\u201330. https:\/\/doi.org\/10.3109\/s10165-011-0571-z.","journal-title":"Mod Rheumatol"},{"issue":"10","key":"2489_CR16","doi-asserted-by":"publisher","first-page":"e6205","DOI":"10.1097\/MD.0000000000006205","volume":"96","author":"M Ebbo","year":"2017","unstructured":"Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, Saadoun D, Audia S, Rigolet A, Terrier B, Perlat A, Guillaud C, Renou F, Bernit E, Costedoat-Chalumeau N, Harl\u00e9 JR, Schleinitz N. Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series. Medicine. 2017;96(10):e6205. https:\/\/doi.org\/10.1097\/MD.0000000000006205.","journal-title":"Medicine"},{"issue":"6","key":"2489_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bjophthalmol-2017-310584","volume":"102","author":"J Park","year":"2018","unstructured":"Park J, Lee MJ, Kim N, Kim JE, Park SW, Choung HK, Khwarg SI. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2018;102(6):736\u201341. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310584.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2489_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/ICU.0000000000000427","volume":"28","author":"L Derzko-Dzulynsky","year":"2017","unstructured":"Derzko-Dzulynsky L. IgG4-related disease in the eye and ocular adnexa. Curr Opin Ophthalmol. 2017;28(6):617\u201322. https:\/\/doi.org\/10.1097\/ICU.0000000000000427.","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"2489_CR19","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.23543","volume":"70","author":"ZS Wallace","year":"2018","unstructured":"Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, et al. An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care Res. 2018;70(11):1671\u20138. https:\/\/doi.org\/10.1002\/acr.23543.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"2489_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR\/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77\u201387. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216561.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2489_CR21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00535-006-1908-9","volume":"41","author":"H Hamano","year":"2006","unstructured":"Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41(12):1197\u2013205. https:\/\/doi.org\/10.1007\/s00535-006-1908-9.","journal-title":"J Gastroenterol"},{"issue":"2","key":"2489_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejrad.2009.06.010","volume":"76","author":"Y Fujinaga","year":"2010","unstructured":"Fujinaga Y, Kadoya M, Kawa S, Hamano H, Ueda K, Momose M, Kawakami S, Yamazaki S, Hatta T, Sugiyama Y. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76(2):228\u201338. https:\/\/doi.org\/10.1016\/j.ejrad.2009.06.010.","journal-title":"Eur J Radiol"},{"issue":"6","key":"2489_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2169\/internalmedicine.49.3038","volume":"49","author":"K Takuma","year":"2010","unstructured":"Takuma K, Kamisawa T, Anjiki H, Egawa N, Igarashi Y. Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med. 2010;49(6):529\u201333. https:\/\/doi.org\/10.2169\/internalmedicine.49.3038.","journal-title":"Intern Med"},{"issue":"6","key":"2489_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","volume":"43","author":"ZS Wallace","year":"2014","unstructured":"Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43(6):806\u201317. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.11.008.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"2489_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/acr.22058","volume":"66","author":"M Ebbo","year":"2014","unstructured":"Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N, Lifermann F, Palat S, Haroche J, Mariette X, Godeau B, Bernit E, Costedoat-Chalumeau N, Papo T, Hamidou M, Harl\u00e9 JR, Schleinitz N. Usefulness of 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res. 2014;66(1):86\u201396. https:\/\/doi.org\/10.1002\/acr.22058.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"2489_CR26","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/kex234","volume":"56","author":"A Berti","year":"2017","unstructured":"Berti A, Della-Torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, Campochiaro C, Ramirez GA, Bozzalla Cassione E, Bozzolo E, Pedica F, Castiglioni I, Arcidiacono PG, Balzano G, Falconi M, Gianolli L, Dagna L. Quantitative measurement of 18F-FDG PET\/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology. 2017;56(12):2084\u201392. https:\/\/doi.org\/10.1093\/rheumatology\/kex234.","journal-title":"Rheumatology"},{"issue":"10","key":"2489_CR27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/bjophthalmol-2015-307437","volume":"100","author":"A Wu","year":"2016","unstructured":"Wu A, Andrew NH, McNab AA, Selva D. Bilateral IgG4-related ophthalmic disease: a strong indication for systemic imaging. Br J Ophthalmol. 2016;100(10):1409\u201311. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307437.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2489_CR28","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","volume":"34","author":"Y Zen","year":"2010","unstructured":"Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812\u20139. https:\/\/doi.org\/10.1097\/PAS.0b013e3181f7266b.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2489_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1751-2980.2012.00583.x","volume":"13","author":"H Igarashi","year":"2012","unstructured":"Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, et al. Relationship between pancreatic and\/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases. J Dig Dis. 2012;13(5):274\u20139. https:\/\/doi.org\/10.1111\/j.1751-2980.2012.00583.x.","journal-title":"J Dig Dis"},{"issue":"1","key":"2489_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","volume":"9","author":"VS Mahajan","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014;9(1):315\u201347. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104708.","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"2489_CR31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702\u201314. https:\/\/doi.org\/10.1038\/s41584-020-0500-7.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"2489_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/art.40469","volume":"70","author":"E Della-Torre","year":"2018","unstructured":"Della-Torre E, Bozzalla-Cassione E, Sciorati C, Ruggiero E, Lanzillotta M, Bonfiglio S, Mattoo H, Perugino CA, Bozzolo E, Rovati L, Arcidiacono PG, Balzano G, Lazarevic D, Bonini C, Falconi M, Stone JH, Dagna L, Pillai S, Manfredi AA. A CD8\u03b1- subset of CD4+SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment. Arthritis Rheumatol. 2018;70(7):1133\u201343. https:\/\/doi.org\/10.1002\/art.40469.","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"2489_CR33","first-page":"30741","volume":"S0091-6749","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Kaneko N, Maehara T, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Della-Torre E, Murphy SJH, et al. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J Allergy Clin Immunol. 2020;S0091-6749(20):30741\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2489_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/cells8020140","volume":"8","author":"Y Nagafuchi","year":"2019","unstructured":"Nagafuchi Y, Shoda H, Fujio K. Immune profiling and precision medicine in systemic lupus erythematosus. Cells. 2019;8(2):140. https:\/\/doi.org\/10.3390\/cells8020140.","journal-title":"Cells"},{"issue":"5","key":"2489_CR35","doi-asserted-by":"publisher","first-page":"e0125331","DOI":"10.1371\/journal.pone.0125331","volume":"10","author":"H Du","year":"2015","unstructured":"Du H, Shi L, Chen P, Yang W, Xun Y, Yang C, Zhao L, Zhou Y, Chen G. Prohibitin is involved in patients with IgG4 related disease. Plos One. 2015;10(5):e0125331. https:\/\/doi.org\/10.1371\/journal.pone.0125331.","journal-title":"Plos One"},{"issue":"4","key":"2489_CR36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/gutjnl-2017-314548","volume":"67","author":"LM Hubers","year":"2018","unstructured":"Hubers LM, Vos H, Schuurman AR, Erken R, Oude Elferink RP, Burgering B, van de Graaf SFJ, Beuers U. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018;67(4):728\u201335. https:\/\/doi.org\/10.1136\/gutjnl-2017-314548.","journal-title":"Gut"},{"issue":"453","key":"2489_CR37","doi-asserted-by":"publisher","first-page":"eaaq0997","DOI":"10.1126\/scitranslmed.aaq0997","volume":"10","author":"M Shiokawa","year":"2018","unstructured":"Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, Yamazaki H, Morita T, Marui S, Sogabe Y, et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018;10(453):eaaq0997.","journal-title":"Sci Transl Med"},{"issue":"2","key":"2489_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","volume":"143","author":"CA Perugino","year":"2019","unstructured":"Perugino CA, AlSalem SB, Mattoo H, Della-Torre E, Mahajan V, Ganesh G, Allard-Chamard H, Wallace Z, Montesi SB, Kreuzer J, et al. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol. 2019;143(2):736\u2013745.e736.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2489_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. ACR\/EULAR IgG4-RD classification criteria committee: clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78(3):406\u201312. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214603.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2489_CR40","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/rheumatology\/keaa221","volume":"59","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Campochiaro C, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L, Della-Torre E. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. Rheumatology. 2020;59(9):2435\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/keaa221.","journal-title":"Rheumatology"},{"issue":"8","key":"2489_CR41","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zeng Q, Zhu L, Gao J, Wang Z, Wang Z, Yang F, Wang K, Chen D, Xia C, Zhang S, Wang Y, Shen D, Yu G, Li ZG. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. Rheumatology. 2020;59(8):2115\u201323. https:\/\/doi.org\/10.1093\/rheumatology\/kez669.","journal-title":"Rheumatology"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02489-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-021-02489-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02489-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T16:03:22Z","timestamp":1617206602000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02489-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02489-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"17 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of Peking University People\u2019s Hospital approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}